|
Gary A. Lyons joined us as a director in October 2005. Mr. Lyons has served as President, Chief Executive Officer and as a member of the Board of Directors of Neurocrine Bosciences since joining the Company in 1993. Prior to joining Neurocrine, he held a number of senior management positions at Genentech including Vice President of Business Development and Vice President of Sales as well as being a member of Genentech's Executive Committee. Mr. Lyons was responsible for international licensing, acquisitions and partnering, was responsible for Genentech's Corporate Venture Program and had operating responsibility for Genentech's two subsidiaries, Genentech Canada, Inc. and Genentech Limited (Japan). He holds a B.S. in marine biology from the University of New Hampshire and an M.B.A. from Northwestern University's J.L. Kellogg Graduate School of Management. Mr. Lyons currently serves on the Board of Directors of Intrabiotics Pharmaceuticals, Inc. and Vical, Inc. | 